In summary, we were able to establish two different TR-FRET-based immunoassays to measure (I) total (physiological and polyQ-expanded) full-length ataxin-3 and (II) polyQ-expanded ataxin-3 in PBMCs of SCA3 subjects. The gene discussed is ATXN3; the disease is Spinocerebellar ataxia type 3.